Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Contributions of HLA haplotypes, IL8 level and Toxoplasma gondii infection in defining celiac disease's phenotypes.

Rostami-Nejad M, Hejazi SH, Peña AS, Asadzadeh-Aghdaei H, Rostami K, Volta U, Zali MR.

BMC Gastroenterol. 2018 May 18;18(1):66. doi: 10.1186/s12876-018-0796-9.

2.

Immunogenetic Pathogenesis of Celiac Disease and Non-celiac Gluten Sensitivity.

Escudero-Hernández C, Peña AS, Bernardo D.

Curr Gastroenterol Rep. 2016 Jul;18(7):36. doi: 10.1007/s11894-016-0512-2. Review.

PMID:
27216895
3.

Segmental pneumatosis cystoides coli: computed tomography-facilitated diagnosis.

Ksiadzyna D, Peña AS.

Rev Esp Enferm Dig. 2016 Aug;108(8):510-3. doi: 10.17235/reed.2015.3790/2015.

4.

What is the best histopathological classification for celiac disease? Does it matter?

Peña AS.

Gastroenterol Hepatol Bed Bench. 2015 Fall;8(4):239-43. No abstract available.

5.

Central America in Transition: From Maize to Wheat Challenges and Opportunities.

Peña AS, Crusius JB.

Nutrients. 2015 Aug 26;7(9):7163-71. doi: 10.3390/nu7095330. Review.

6.

Intestinal microbiota as modulators of the immune system.

Sánchez B, Gueimonde M, Peña AS, Bernardo D.

J Immunol Res. 2015;2015:159094. doi: 10.1155/2015/159094. Epub 2015 Mar 2. No abstract available.

7.

Immunogenetics of non celiac gluten sensitivity.

Peña AS.

Gastroenterol Hepatol Bed Bench. 2014 Winter;7(1):1-5. No abstract available.

8.

Non-celiac wheat sensitivity is not a new entity.

Rúa EC, Drut R, Peña AS.

Am J Gastroenterol. 2013 Nov;108(11):1805. doi: 10.1038/ajg.2013.307. No abstract available.

PMID:
24192952
9.

Abdominal splenosis.

Ksiadzyna D, Peña AS.

Rev Esp Enferm Dig. 2011 Aug;103(8):421-6. Review. English, Spanish.

10.
11.

Disease activity and venous thromboembolism in inflammatory bowel disease.

Koutroubakis IE, Pena AS.

Lancet. 2010 May 15;375(9727):1689; author reply 1690-1. doi: 10.1016/S0140-6736(10)60727-1. No abstract available.

PMID:
20472159
12.

Effect of B vitamin supplementation on plasma homocysteine levels in celiac disease.

Hadithi M, Mulder CJ, Stam F, Azizi J, Crusius JB, Peña AS, Stehouwer CD, Smulders YM.

World J Gastroenterol. 2009 Feb 28;15(8):955-60.

13.

Indications and challenges of probiotics, prebiotics, and synbiotics in the management of arthralgias and spondyloarthropathies in inflammatory bowel disease.

Karimi O, Peña AS.

J Clin Gastroenterol. 2008 Sep;42 Suppl 3 Pt 1:S136-41. doi: 10.1097/MCG.0b013e3181662455. Review.

PMID:
18806706
14.

Retrospective analysis of old-age colitis in the Dutch inflammatory bowel disease population.

Hadithi M, Cazemier M, Meijer GA, Bloemena E, Felt-Bersma RJ, Mulder CJ, Meuwissen SG, Pena AS, van Bodegraven AA.

World J Gastroenterol. 2008 May 28;14(20):3183-7.

15.

N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study.

Guijarro LG, Mate J, Gisbert JP, Perez-Calle JL, Marin-Jimenez I, Arriaza E, Olleros T, Delgado M, Castillejo MS, Prieto-Merino D, Gonzalez Lara V, Pena AS.

World J Gastroenterol. 2008 May 14;14(18):2851-7.

16.

Coeliac disease in Dutch patients with Hashimoto's thyroiditis and vice versa.

Hadithi M, de Boer H, Meijer JW, Willekens F, Kerckhaert JA, Heijmans R, Peña AS, Stehouwer CD, Mulder CJ.

World J Gastroenterol. 2007 Mar 21;13(11):1715-22.

17.

Evaluation of oral budesonide in the treatment of active distal ulcerative colitis.

Kolkman JJ, Möllmann HW, Möllmann AC, Penã AS, Greinwald R, Tauschel HD, Hochhaus G.

Drugs Today (Barc). 2004 Jul;40(7):589-601.

PMID:
15510233
18.

Reviewing the mechanism of action of thiopurine drugs: towards a new paradigm in clinical practice.

Cara CJ, Pena AS, Sans M, Rodrigo L, Guerrero-Esteo M, Hinojosa J, García-Paredes J, Guijarro LG.

Med Sci Monit. 2004 Nov;10(11):RA247-54. Epub 2004 Oct 26. Review.

PMID:
15507865
19.

IL-1B promoter polymorphism and Epstein-Barr virus in Dutch patients with gastric carcinoma.

zur Hausen A, Crusius JB, Murillo LS, Alizadeh BZ, Morré SA, Meijer CJ, van den Brule AJ, Peña AS.

Int J Cancer. 2003 Dec 10;107(5):866-7. No abstract available.

20.

The therapeutic spectrum of infliximab and tumor necrosis factor immunomodulation in chronic inflammatory diseases.

Ricart E, Bouma G, Peña AS.

Drugs Today (Barc). 2002 Nov;38(11):725-44. Review.

PMID:
12582457

Supplemental Content

Loading ...
Support Center